News Briefs: PhRMA, Drugmakers Sue Over Medicare Drug Price Negotiation

The Pharmaceutical Research and Manufacturers of America (PhRMA) sued the Biden administration over Medicare drug price negotiation and inflation cap provisions in the Inflation Reduction Act (IRA), arguing that the policies are unconstitutional. Two patient assistance groups, the National Infusion Center Association and the Global Colon Cancer Association, joined the lawsuit, which was filed in the U.S. District Court for the Western District of Texas, per a PhRMA press release. The U.S. Chamber of Commerce, Bristol Myers Squibb, and Merck & Co. Inc. filed their own lawsuits against the drug price provisions of the law in recent weeks, and Biogen Inc.’s CEO said that his firm may do the same. The Chamber of Commerce was a major financial backer of legal efforts to overturn the Affordable Care Act during the 2010s, and it filed an amicus brief in support of the lawsuit that ultimately led to the U.S. Supreme Court’s move to strike down mandatory state Medicaid expansion.

© 2024 MMIT
AIS Health Staff

AIS Health Staff

Related Posts

iv-therapy
February 8

Incorporating Pharmacy Spending in Value-Based Payment Models Remains Challenging

READ MORE
pills-on-bills
February 8

As Reform Efforts Persisted, PBM Trade Association Set Its Lobbying Record in 2023

READ MORE
optum
February 8

Direct-to-Consumer Prescribing Could Have Downsides

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today